Novel percutaneous mechanical circulatory support devices and their expanding applications

References

• Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the benchmark registry. Eur Heart J. 2003;24(19):1763–1770.
   PubMed Web of Science ®Google Scholar
• Perera D, Stables R, Thomas M, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304(8):867–874. doi:10.1001/jama.2010.1190.
   PubMed Web of Science ®Google Scholar
• Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011;306(12):1329–1337. doi:10.1001/jama.2011.1280.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–1296. doi:10.1056/NEJMoa1208410.
   PubMed Web of Science ®Google Scholar
• Abrams D, Combes A, Brodie D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol. 2014;63(25 Pt A):2769–2778. doi:10.1016/j.jacc.2014.03.046.
   PubMed Web of Science ®Google Scholar
• Lafçı G, Budak AB, Yener AÜ, et al. Use of extracorporeal membrane oxygenation in adults. Hear Lung Circ. 2014;23(1):10–23. doi:10.1016/j.hlc.2013.08.009.
   PubMed Web of Science ®Google Scholar
• Gregoric I, Bermudez C. Current types of devices for mechanical circulatory support. In: Kormos R, Miller LW, eds. Mechanical circulatory support. Philadelphia (PA): Saunders; 2012. p. 99–117.
   Google Scholar
• Tanaka A, Tuladhar SM, Onsager D, et al. The subclavian intraaortic balloon pump: a compelling bridge device for advanced heart failure. Ann Thorac Surg. July 2015. doi:10.1016/j.athoracsur.2015.05.087.
   Web of Science ®Google Scholar
• Aaronson K, Pagani F. Mechanical circulatory support. In: Mann DL, Zipes DP, Libby P, et al., editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. Vol. 10. Philadelphia (PA): Saunders; 2015. p. 590–599.
   Google Scholar
• Estep JD, Cordero-Reyes AM, Bhimaraj A, et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail. 2013;1(5):382–388. doi:10.1016/j.jchf.2013.06.002.
   PubMed Web of Science ®Google Scholar
• White JM. Ruygrok PN. Intra-aortic balloon counterpulsation in contemporary practice - where are we? Heart Lung Circ. 2015;24(4):335–341. doi:10.1016/j.hlc.2014.12.003.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341(9):625–634. doi:10.1056/NEJM199908263410901.
   PubMed Web of Science ®Google Scholar
• Ohman EM, Nanas J, Stomel RJ, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005;19(1):33–39. doi:10.1007/s11239-005-0938-0.
   PubMed Web of Science ®Google Scholar
• Sjauw KD, Engström AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30(4):459–468. doi:10.1093/eurheartj/ehn602.
   PubMed Web of Science ®Google Scholar
• Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2010;38(1):152–160. doi:10.1097/CCM.0b013e3181b78671.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–1296. doi:10.1056/NEJMoa1208410.
   PubMed Web of Science ®Google Scholar
• Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011;306(12):1329–1337. doi:10.1001/jama.2011.1280.
   PubMed Web of Science ®Google Scholar
• Pilarczyk K, Boening A, Jakob H, et al. Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials†. Eur J Cardiothorac Surg. 2016;49:5–17. doi:10.1093/ejcts/ezv258.
   PubMed Web of Science ®Google Scholar
• Sjauw KD, Engström AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30(4):459–468. doi:10.1093/eurheartj/ehn602.
   PubMed Web of Science ®Google Scholar
• Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome*. Crit Care Med. 2010;38(1):152–160. doi:10.1097/CCM.0b013e3181b78671.
   PubMed Web of Science ®Google Scholar
• Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the benchmark® registry. Eur Heart J. 2003;24(19):1763–1770. doi:10.1016/j.ehj.2003.07.002.
   PubMed Web of Science ®Google Scholar
• Curtis JP, Rathore SS, Wang Y, et al. Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2012;5(1):21–30. doi:10.1161/CIRCOUTCOMES.110.960385.
   PubMed Web of Science ®Google Scholar
• Takeda K, Takayama H, Naka Y. Left ventricular assist devices and total artificial heart. In: Sellke FW, Del Nido PJ, Swanson S, editors. Sabiston and spencer’s surgery of the chest. Vol. 9. Amsterdam: Elsevier; 2016. p. 1707–1728.
   Google Scholar
• Theologou T, Bashir M, Rengarajan A, et al. Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass grafting. Cochrane Database Syst Rev. 2011;(1):CD004472. doi:10.1002/14651858.CD004472.pub3
   Google Scholar
• Shi M, Huang J, Pang L, et al. Preoperative insertion of an intra-aortic balloon pump improved the prognosis of high-risk patients undergoing off-pump coronary artery bypass grafting. J Int Med Res. 2011;39:1163–1168. doi:10.1177/147323001103900404.
   PubMed Web of Science ®Google Scholar
• Wilczyński M, Krzych LJ, Bis J, et al. Effect of gender on efficacy of preoperative intra-aortic balloon pump in high risk patients undergoing surgical coronary revascularisation. Kardiol Pol. 2010;68(12):1361–1368.
   PubMed Web of Science ®Google Scholar
• Metz D, Stiller M, Silber R-E, et al. [Prophylactic intraaortic balloon pumping in high-risk cardiac surgery patients]. Med Klin Intensivmed Notfmed. 2011;106(2):125–131. doi:10.1007/s00063-011-0048-z.
   PubMed Web of Science ®Google Scholar
• Ranucci M, Castelvecchio S, Biondi A, et al. A randomized controlled trial of preoperative intra-aortic balloon pump in coronary patients with poor left ventricular function undergoing coronary artery bypass surgery*. Crit Care Med. 2013;41(11):2476–2483. doi:10.1097/CCM.0b013e3182978dfc.
   PubMed Web of Science ®Google Scholar
• Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg. 2011;6(1):147. doi:10.1186/1749-8090-6-147.
   PubMed Web of Science ®Google Scholar
• Erdogan HB, Goksedef D, Erentug V, et al. In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. J Card Surg. 2006;21(4):342–346. doi:10.1111/j.1540-8191.2006.00268.x.
   PubMed Web of Science ®Google Scholar
• Rihal CS, Naidu SS, Givertz MM, et al. SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino America. J Am Coll Cardiol. 2015;65(19):e7–e26. doi:10.1016/j.jacc.2015.03.036.
   PubMedGoogle Scholar
• Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276–1283. doi:10.1093/eurheartj/ehi161.
   PubMed Web of Science ®Google Scholar
• Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469.e1-e8. doi:10.1016/j.ahj.2006.05.031.
   PubMed Web of Science ®Google Scholar
• Ostadal P, Mlcek M, Holy F, et al. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythmia Electrophysiol. 2012;5(6):1202–1206. doi:10.1161/CIRCEP.112.973123.
   PubMed Web of Science ®Google Scholar
• Huang SC, Yu HY, Ko WJ, et al. Pressure criterion for placement of distal perfusion catheter to prevent limb ischemia during adult extracorporeal life support. J Thorac Cardiovasc Surg. 2004;128(5):776–777. doi:10.1016/j.jtcvs.2004.03.042.
   PubMed Web of Science ®Google Scholar
• De Souza CF, De Souza Brito F, De Lima VC, et al. Percutaneous mechanical assistance for the failing heart. J Interv Cardiol. 2010;23(2):195–202. doi:10.1111/j.1540-8183.2010.00536.x.
   PubMed Web of Science ®Google Scholar
• Cevik C, Nguyen HT, Civitello AB, et al. Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock: bridge to myectomy. Ann Thorac Surg. 2012;93(3):978–980. doi:10.1016/j.athoracsur.2011.07.079.
   PubMed Web of Science ®Google Scholar
• Neuzil P, Kmonicek P, Skoda J, et al. Temporary (short-term) percutaneous left ventricular assist device (Tandem Heart) in a patient with STEMI, multivessel coronary artery disease, cardiogenic shock and severe peripheral artery disease. Acute Card Care. 2009;11(3):146–150. doi:10.1080/17482940903055976.
   PubMedGoogle Scholar
• Thomas JL, Al-Ameri H, Economides C, et al. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock. J Invasive Cardiol. 2010;22(8):360–364.
   PubMed Web of Science ®Google Scholar
• Kar B, Gregoric ID, Basra SS, et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57(6):688–696. doi:10.1016/j.jacc.2010.08.613.
   PubMed Web of Science ®Google Scholar
• Bagai J, Webb D, Kasasbeh E, et al. Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest. J Invasive Cardiol. 2011;23(4):141–147.
   PubMed Web of Science ®Google Scholar
• Alli OO, Singh IM, Holmes DR, et al. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience. Catheter Cardiovasc Interv. 2012;80(5):728–734. doi:10.1002/ccd.23465.
   PubMed Web of Science ®Google Scholar
• Esper SA, Bermudez C, Dueweke EJ, et al. Extracorporeal membrane oxygenation support in acute coronary syndromes complicated by cardiogenic shock. Catheter Cardiovasc Interv. 2015;86(Suppl 1):S45–S50. doi:10.1002/ccd.25871.
   Google Scholar
• Raess DH, Weber DM. Impella 2.5. J Cardiovasc Transl Res. 2009;2(2):168–172. doi:10.1007/s12265-009-9099-4.
   PubMed Web of Science ®Google Scholar
• Lotun K, Shetty R, Patel M, et al. Percutaneous left axillary artery approach for Impella 2.5 liter circulatory support for patients with severe aortoiliac arterial disease undergoing high-risk percutaneous coronary intervention. J Interv Cardiol. 2012;25(2):210–213. doi:10.1111/j.1540-8183.2011.00696.x.
   PubMed Web of Science ®Google Scholar
• Henriques JPS, Remmelink M, Baan J, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol. 2006;97(7):990–992. doi:10.1016/j.amjcard.2005.10.037.
   PubMed Web of Science ®Google Scholar
• Rashed A, Won S, Saad M, et al. Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to takotsubo cardiomyopathy. Case Reports. 2015;may07 2:bcr2014208354–bcr2014208354. doi:10.1136/bcr-2014-208354.
   PubMedGoogle Scholar
• Desai N, Chaudhry K, Aji J. Impella left ventricular assist device in cardiac arrest after spinal anaesthesia for caesarean section. BMJ Case Rep. 2015;2015. doi:10.1136/bcr-2015-211958.
   Google Scholar
• Martinez CA, Singh V, Londoño JC, et al. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction. Catheter Cardiovasc Interv. 2012;80(7):1201–1209. doi:10.1002/ccd.24303.
   PubMed Web of Science ®Google Scholar
• Cheng A, Swartz MF, Massey HT. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO J. 2013;59(5):533–536. doi:10.1097/MAT.0b013e31829f0e52.
   PubMed Web of Science ®Google Scholar
• Pulido JN, Mayo C, Park SJ, et al. Percutaneous left ventricular assist devices: clinical uses, future applications, and anesthetic considerations. J Cardiothorac Vasc Anesth. 2010;24(3):478–486. doi:10.1053/j.jvca.2009.10.026.
   PubMed Web of Science ®Google Scholar
• Sjauw KD, Remmelink M, Baan J, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol. 2008;51(10):1044–1046. doi:10.1016/j.jacc.2007.10.050.
   PubMed Web of Science ®Google Scholar
• Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–1588. doi:10.1016/j.jacc.2008.05.065.
   PubMed Web of Science ®Google Scholar
• Lauten A, Engstrom AE, Jung C, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-Registry. Circ Hear Fail. 2012;6(1):23–30. doi:10.1161/CIRCHEARTFAILURE.112.967224.
   PubMed Web of Science ®Google Scholar
• O’Neill WW, Schreiber T, Wohns DHW, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014;27(1):1–11. doi:10.1111/joic.12080.
   PubMed Web of Science ®Google Scholar
• Casassus F, Corre J, Leroux L, et al. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction. J Interv Cardiol. 2015;28(1):41–50. doi:10.1111/joic.12172.
   PubMed Web of Science ®Google Scholar
• Dixon SR, Henriques JPS, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;2(2):91–96. doi:10.1016/j.jcin.2008.11.005.
   PubMed Web of Science ®Google Scholar
• O’Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717–1727. doi:10.1161/CIRCULATIONAHA.112.098194.
   PubMed Web of Science ®Google Scholar
• Dangas GD, Kini AS, Sharma SK, et al. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Am J Cardiol. 2014;113(2):222–228.
   PubMed Web of Science ®Google Scholar
• Kovacic JC, Kini A, Banerjee S, et al. Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial. J Interv Cardiol. 2015;28(1):32–40. doi:10.1111/joic.12166.
   PubMed Web of Science ®Google Scholar
• Maini B, Naidu SS, Mulukutla S, et al. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv. 2012;80(5):717–725. doi:10.1002/ccd.23403.
   PubMed Web of Science ®Google Scholar
• Sjauw KD, Konorza T, Erbel R, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 Device. The Europella registry. J Am Coll Cardiol. 2009;54(25):2430–2434. doi:10.1016/j.jacc.2009.09.018.
   PubMed Web of Science ®Google Scholar
• Cohen MG, Matthews R, Maini B, et al. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: real-world versus clinical trial experience. Am Heart J. 2015;170(5):872–879. doi:10.1016/j.ahj.2015.08.009.
   PubMed Web of Science ®Google Scholar
• Engström AE, Cocchieri R, Driessen AH, et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the academic medical center intensive care unit experience. Crit Care Med. 2011;39(9):2072–2079. doi:10.1097/CCM.0b013e31821e89b5.
   PubMed Web of Science ®Google Scholar
• Venugopal V, Spiro J, Zaphiriou A, et al. Percutaneous mechanical ventricular support in acute cardiac care: a UK quaternary centre experience using 2.5L, 3.8L and 5.0L Impella catheters. Cardiol Ther. 2015;4(1):47–58. doi:10.1007/s40119-014-0033-8.
   PubMed Web of Science ®Google Scholar
• Griffith BP, Anderson MB, Samuels LE, et al. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg. 2013;145(2):548–554. doi:10.1016/j.jtcvs.2012.01.067.
   PubMed Web of Science ®Google Scholar
• Lemaire A, Anderson MB, Prendergast T, et al. Outcome of the impella device for acute mechanical circulatory support. Innovations (Phila). 2013;8(1):12–16. doi:10.1097/IMI.0b013e31828e0a8a.
   PubMedGoogle Scholar
• Lima B, Kale P, Gonzalez-Stawinski GV, et al. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117(10):1622–1628. doi:10.1016/j.amjcard.2016.02.038.
   PubMed Web of Science ®Google Scholar
• Choi DC, Anderson MB, Batsides GP. Insertion of the Impella 5.0 left ventricular assist device via right anterior mini-thoracotomy. Innov Technol Tech Cardiothorac Vasc Surg. 2011;6(4):265–266. doi:10.1097/IMI.0b013e31822b36b8.
   Google Scholar
• Schibilsky D, Lausberg H, Haller C, et al. Impella 5.0 Support in INTERMACS II cardiogenic shock patients using right and left axillary artery access. Artif Organs. 2015;39(8):660–663. doi:10.1111/aor.12529.
   PubMed Web of Science ®Google Scholar
• Shah AS, Lee R, Hui DS, et al. Use of a vascular sheath in the axillary artery as an alternative access approach for placing an Impella 5.0 device. Texas Hear Inst J. 2015;42(4):385–388. doi:10.14503/THIJ-14-4337.
   PubMed Web of Science ®Google Scholar
• Chandola R, Cusimano R, Osten M, et al. Severe aortic insufficiency secondary to 5L Impella device placement. J Card Surg. 2012;27(3):400–402. doi:10.1111/j.1540-8191.2012.01454.x.
   PubMed Web of Science ®Google Scholar
• Combes A, Bacchetta M, Brodie D, et al. Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care. 2012;18(1):99–104. doi:10.1097/MCC.0b013e32834ef412.
   PubMed Web of Science ®Google Scholar
• Hoopes CW, Gurley JC, Zwischenberger JB, et al. Mechanical support for pulmonary veno-occlusive disease: combined atrial septostomy and venovenous extracorporeal membrane oxygenation. Semin Thorac Cardiovasc Surg. 2012;24(3):232–234. doi:10.1053/j.semtcvs.2012.03.003.
   PubMedGoogle Scholar
• Shin TG, Choi J-H, Jo IJ, et al. Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation. Crit Care Med. 2011;39(1):1–7. doi:10.1097/CCM.0b013e3181feb339.
   PubMed Web of Science ®Google Scholar
• Chen Y-S, Lin J-W, Yu H-Y, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet (London, England). 2008;372(9638):554–561. doi:10.1016/S0140-6736(08)60958-7.
   PubMed Web of Science ®Google Scholar
• Ventetuolo CE, Muratore CS. Extracorporeal life support in critically ill adults. Am J Respir Crit Care Med. 2014;190(5):497–508. doi:10.1164/rccm.201404-0736CI.
   PubMed Web of Science ®Google Scholar
• Nagao K, Hayashi N, Kanmatsuse K, et al. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol. 2000;36(3):776–783.
   PubMed Web of Science ®Google Scholar
• Chen JS, Ko WJ, Yu HY, et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med. 2006;34(4):950–957. doi:10.1097/01.CCM.0000206103.35460.1F.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chao A, Yu H, et al. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol. 2003;41(2). doi:10.1016/S0735-1097(02)02716-X.
   Web of Science ®Google Scholar
• Sheu JJ, Tsai TH, Lee FY, et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med. 2010;38(9):1810–1817. doi:10.1097/CCM.0b013e3181e8acf7.
   PubMed Web of Science ®Google Scholar
• Tsao NW, Shih CM, Yeh JS, et al. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock. J Crit Care. 2012;27(5):530.e1-e11. doi:10.1016/j.jcrc.2012.02.012.
   PubMed Web of Science ®Google Scholar
• Kagawa E, Dote K, Kato M, et al. Should we emergently revascularize occluded coronaries for cardiac arrest?: rapid-response extracorporeal membrane oxygenation and intra-arrest percutaneous coronary intervention. Circulation. 2012;126(13):1605–1613. doi:10.1161/CIRCULATIONAHA.111.067538.
   PubMed Web of Science ®Google Scholar
• De Waha S, Fuernau G, Desch S, et al. Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort. EuroIntervention. 2016;11(12):1363–1371. doi:10.4244/EIJV11I12A265.
   PubMed Web of Science ®Google Scholar
• Biscotti M, Agerstrand C, Abrams D, et al. One hundred transports on extracorporeal support to an extracorporeal membrane oxygenation center. Ann Thorac Surg. 2015;100(1):34–39. discussion 39-40. doi:10.1016/j.athoracsur.2015.02.037
   PubMed Web of Science ®Google Scholar
• Wagner K, Sangolt GK, Risnes I, et al. Transportation of critically ill patients on extracorporeal membrane oxygenation. Perfusion. 2008;23(2):101–106. doi:10.1177/0267659108096261.
   PubMed Web of Science ®Google Scholar
• Bryner B, Cooley E, Copenhaver W, et al. Two decades’ experience with interfacility transport on extracorporeal membrane oxygenation. Ann Thorac Surg. 2014;98(4):1363–1370. doi:10.1016/j.athoracsur.2014.06.025.
   PubMed Web of Science ®Google Scholar
• Beurtheret S, Mordant P, Paoletti X, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J. 2013;34(2):112–120. doi:10.1093/eurheartj/ehs081.
   PubMed Web of Science ®Google Scholar
• Alwardt CM, Wilson DS, Alore ML, et al. Performance and safety of an integrated portable extracorporeal life support system for adults. J Extra Corpor Technol. 2015;47(1):38–43.
   PubMedGoogle Scholar
• Arlt M, Philipp A, Voelkel S, et al. Early experiences with miniaturized extracorporeal life-support in the catheterization laboratory. Eur J Cardiothorac Surg. 2012;42(5):858–863. doi:10.1093/ejcts/ezs176.
   PubMed Web of Science ®Google Scholar
• Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ. 2008;17(Suppl 4):S41–S47. doi:10.1016/j.hlc.2008.08.009.
   Google Scholar
• Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2014;97(2):610–616. doi:10.1016/j.athoracsur.2013.09.008.
   PubMed Web of Science ®Google Scholar
• Saeed D, Stosik H, Islamovic M, et al. Femoro-femoral versus atrio-aortic extracorporeal membrane oxygenation: selecting the ideal cannulation technique. Artif Organs. 2014;38(7):549–555. doi:10.1111/aor.12245.
   PubMed Web of Science ®Google Scholar
• Aiyagari RM, Rocchini AP, Remenapp RT, et al. Decompression of the left atrium during extracorporeal membrane oxygenation using a transseptal cannula incorporated into the circuit. Crit Care Med. 2006;34(10):2603–2606. doi:10.1097/01.CCM.0000239113.02836.F1.
   PubMed Web of Science ®Google Scholar
• Fumagalli R, Bombino M, Borelli M, et al. Percutaneous bridge to heart transplantation by venoarterial ECMO and transaortic left ventricular venting. Int J Artif Organs. 2004;27(5):410–413.
   PubMed Web of Science ®Google Scholar
• Madershahian N, Liakopoulos OJ, Wippermann J, et al. The impact of intraaortic balloon counterpulsation on bypass graft flow in patients with peripheral ECMO. J Card Surg. 2009;24:265–268. doi:10.1111/j.1540-8191.2009.00807.x.
   PubMed Web of Science ®Google Scholar
• Kapur NK, Paruchuri V, Korabathina R, et al. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure. J Hear Lung Transplant. 2011;30(12):1360–1367. doi:10.1016/j.healun.2011.07.005.
   PubMed Web of Science ®Google Scholar
• Takayama H, Naka Y, Kodali SK, et al. A novel approach to percutaneous right-ventricular mechanical support. Eur J Cardio-thoracic Surg. 2012;41(2):423–426. doi:10.1016/j.ejcts.2011.05.041.
   PubMed Web of Science ®Google Scholar
• Cheung AW, White CW, Davis MK, et al. Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes. J Hear Lung Transplant. 2014;33(8):794–799. doi:10.1016/j.healun.2014.02.028.
   PubMed Web of Science ®Google Scholar
• Margey R, Chamakura S, Siddiqi S, et al. First experience with implantation of a percutaneous right ventricular Impella right side percutaneous support device as a bridge to recovery in acute right ventricular infarction complicated by cardiogenic shock in the United States. Circ Cardiovasc Interv. 2013;6(3):e37–e38. doi:10.1161/CIRCINTERVENTIONS.113.000283.
   PubMed Web of Science ®Google Scholar
• Chen JM, Levin HR, Rose EA, et al. Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg. 1996;61(1):305–310. discussion 311-313. doi:10.1016/0003-4975(95)01010-6
   PubMed Web of Science ®Google Scholar
• Klima U, Ringes-Lichtenberg S, Warnecke G, et al. Severe right heart failure after heart transplantation. A single-center experience. Transpl Int. 2005;18(3):326–332. doi:10.1111/j.1432-2277.2004.00059.x.
   PubMed Web of Science ®Google Scholar
• Itagaki S, Hosseinian L, Varghese R. Right ventricular failure after cardiac surgery: management strategies. Semin Thorac Cardiovasc Surg. 2012;24(3):188–194. doi:10.1053/j.semtcvs.2012.08.001.
   PubMedGoogle Scholar
• Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34(12):1549–1560. doi:10.1016/j.healun.2015.08.018.
   PubMed Web of Science ®Google Scholar
• Kapur NK, Paruchuri V, Jagannathan A, et al. Mechanical circulatory support for right ventricular failure. JACC Heart Fail. 2013;1(2):127–134. doi:10.1016/j.jchf.2013.01.007.
   PubMed Web of Science ®Google Scholar
• Schmack B, Weymann A, Popov A-F, et al. Concurrent left ventricular assist device (LVAD) Implantation and percutaneous temporary RVAD support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure. Med Sci Monit Basic Res. 2016;22:53–57. doi:10.12659/MSMBR.898897.
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Einhorn BN, Cohen HA. Current status of percutaneous right ventricular assist devices: first-in-man use of a novel dual lumen cannula. Catheter Cardiovasc Interv. February 2016. doi:10.1002/ccd.26348.
   Web of Science ®Google Scholar
• Kapur NK, Paruchuri V, Pham DT, et al. Hemodynamic effects of left atrial or left ventricular cannulation for acute circulatory support in a bovine model of left heart injury. ASAIO J. 2015;61(3):301–306. doi:10.1097/MAT.0000000000000195.
   PubMed Web of Science ®Google Scholar
• Kapur NK, Jumean M, Ghuloom A, et al. First successful use of 2 axial flow catheters for percutaneous biventricular circulatory support as a bridge to a durable left ventricular assist device. Circ Heart Fail. 2015;8(5):1006–1008. doi:10.1161/CIRCHEARTFAILURE.115.002374.
   PubMed Web of Science ®Google Scholar
• Bruenger F, Kizner L, Weile J, et al. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015;38(2):113–116. doi:10.5301/ijao.5000382.
   PubMed Web of Science ®Google Scholar